Author

Étienne Rouleau

Institut Gustave RoussyORCID 0000-0002-9046-257XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Agathe LaratteiD· 1 shared Agathe PeltieriD· 1 shared Alexis Benjamin CortotiD· 1 shared Alicia Tran-DieniD· 1 shared Amélie RoehrigiD· 1 shared Audrey VinchentiD· 1 shared Benjamin BesseiD· 1 shared Célia GuériniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agathe LaratteORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 2, 2026

Single-cell trajectories in metastatic urothelial carcinoma reveal tumor-immune reprogramming and macrophage-driven resistance to PD-(L)1 blockade

Ronan Flippot, Amélie Roehrig, Julien Vibert…·Yohann Loriot

This study uses single-cell RNA sequencing to analyze metastatic urothelial carcinoma and identifies macrophage-driven resistance to PD-(L)1 blockade as a key mechanism.

DOI 10.64898/2026.03.31.715549

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyMolecular OncologyPeer-reviewedFeb 20, 2025

MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

Célia Guérin, Audrey Vinchent, Marie Fernandes…·David Tulasne

This paper identifies N-lobe MET mutations in HPRCC that require ligand stimulation for activation, unlike kinase domain mutations, and shows their sensitivity to MET inhibitors.

8 citations

humanproteomics

𝕏 PostBluesky